Typlit has designed a unique cutting and ligation device in laparoscopic surgery.
We already have various prototypes as well as in cadaver procedures. Our regulatory strategy is significantly de-risked because of predicate devices and because of clinical trials conducted. Our IP strategy is managed by Kilpatrick Townsend.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free